|
|
Volumn 358, Issue 6363, 2017, Pages 573-
|
|
Gut microbes shape response to cancer immunotherapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CHECKPOINT KINASE INHIBITOR;
IMMUNOLOGIC AGENT;
INTERLEUKIN 12;
PROGRAMMED DEATH 1 LIGAND 1;
ANTINEOPLASTIC AGENT;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 RECEPTOR;
BLADDER CANCER;
CANCER IMMUNOTHERAPY;
FECAL MICROBIOTA TRANSPLANTATION;
HUMAN;
INTESTINE FLORA;
KIDNEY CANCER;
LUNG CANCER;
MELANOMA;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TREATMENT RESPONSE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
DRUG RESISTANCE;
IMMUNOLOGY;
IMMUNOTHERAPY;
MOUSE;
NEOPLASM;
VERRUCOMICROBIA;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG RESISTANCE, NEOPLASM;
GASTROINTESTINAL MICROBIOME;
HUMANS;
IMMUNOTHERAPY;
MICE;
NEOPLASMS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
VERRUCOMICROBIA;
|
|
EID: 85032951643
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.358.6363.573 Document Type: Note |
|
Times cited : (33)
|
|
References (0)
|